An Italian software company says it has developed a way to detect COVID-19 infections by analyzing a person's speech or cough with no need for a blood test, nose, or anal swab.
Neosperience President Dario Melpignano said Tuesday the system, which detects sounds characteristic of the respiratory disease, was more than 80% accurate. The announcement sent the company's shares up more than 13%.
The project was developed with partners and by using artificial intelligence (AI) embedded in a cloud platform called Neosperience Health Cloud, which has already been used to analyze chest x-rays, the company said in a statement.
Neosperience's shares, listed on the Aim section of the Milan Bourse, were automatically suspended after rising 13.5% to 6.50 euros ($7.69) per share.
"It's just the beginning of a project that has incredible potential because the processing of this sort of data can be effectively used as a screening test," said Alessandro Nizardo Chailly, the chief executive of Neosperience's partner Capsula.
The recording and analysis model could help to detect and diagnose a wide range of pathogens, added Capsula's scientific adviser Giuseppe Andreoni.